Testing effectiveness (Phase 2)Not Yet RecruitingNCT07584031
What this trial is testing
Adebrelimab Plus Full-course Neoadjuvant Therapy for Resectable Locally Advanced ESCC (Phase 2)
Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 200